On 30 October, Astrazeneca revealed that its China President, Leon Wang, was under investigation by Chinese authorities. It ...

to move to Shanghai Reic to continue as head of vaccines and immune therapies Reic takes over from Leon Wang, who has been detained in China Dec 4 (Reuters) - AstraZeneca (AZN.L), opens new tab on ...

Now, the question is whether AstraZeneca became overly aggressive in its ambitions. Last week, the company disclosed that Leon Wang, its executive vice president for international operations and ...

will succeed Leon Wang, “who is on extended leave from the company while under investigation in China,” it said in a statement on Wednesday. Investors have been nervous about AstraZeneca since ...

Leon Wang, the president of AstraZeneca’s China division, was last year detained alongside several other employees amid an investigation into operations in the country. Authorities are looking ...

U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country ...

Also Read: AstraZeneca Unveils Early Data From Chinese-Firm Partnered Oral Weight Loss Drug Citing sources, the report adds that Leon Wang, President of AstraZeneca China, is cooperating with ...

Chinese authorities detained AstraZeneca’s former China head Leon Wang last year and revealed a probe into potential illegal drug importation early this year. Against that backdrop, AstraZeneca ...

Following reports of an ex-AstraZeneca executive being detained in China, the company acknowledged that its current president in the country, Leon Wang, "is cooperating with an ongoing investigation.

LONDON, Nov 6 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason ...

including Leon Wang, President of AstraZeneca's China business. As reported by AstraZeneca's management in a recent conference call to address the matter, the company is not under investigation ...